(Q27025309)

Y. Bi

2

1 reference

S. Li

3

1 reference

Q. Zhang

4

1 reference

G. Zhao

5

1 reference

Y. Guo

6

1 reference

Q. Song

7

1 reference

language of work or name

1 reference

1 July 2014

1 reference

American Journal of Epidemiology

published in

1 reference

volume

180

1 reference

issue

1

1 reference

page(s)

11-4

1 reference

cites work

Global cancer statistics

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWU124

Evidence on the impact of sustained exposure to air pollution on life expectancy from China's Huai River policy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWU124

Air pollution and lung cancer incidence in 17 European cohorts: prospective analyses from the European Study of Cohorts for Air Pollution Effects (ESCAPE).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWU124

The Beta-Carotene and Retinol Efficacy Trial: incidence of lung cancer and cardiovascular disease mortality during 6-year follow-up after stopping beta-carotene and retinol supplements

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWU124

A randomized phase II chemoprevention trial of 13-CIS retinoic acid with or without alpha tocopherol or observation in subjects at high risk for lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWU124

Vitamin E in the primary prevention of cardiovascular disease and cancer: the Women's Health Study: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWU124

Metformin and cancer risk in diabetic patients: a systematic review and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWU124

Reduced risk of colorectal cancer with metformin therapy in patients with type 2 diabetes: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWU124

Metformin for liver cancer prevention in patients with type 2 diabetes: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWU124

Lower risk of cancer in patients on metformin in comparison with those on sulfonylurea derivatives: results from a large population-based follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWU124

The effect of metformin and thiazolidinedione use on lung cancer in diabetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWU124

New users of metformin are at low risk of incident cancer: a cohort study among people with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWU124

Metformin inhibits growth and enhances radiation response of non-small cell lung cancer (NSCLC) through ATM and AMPK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWU124

Metformin attenuates the stimulatory effect of a high-energy diet on in vivo LLC1 carcinoma growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWU124

Metformin prevents tobacco carcinogen--induced lung tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWU124

The use of metformin and the incidence of lung cancer in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWU124

Cohort study of pioglitazone and cancer incidence in patients with diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWU124

The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWU124

Meta-analysis in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWU124

Quantitative synthesis in systematic reviews

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWU124

Quantifying heterogeneity in a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWU124

A genome-wide methylation study on obesity: differential variability and differential methylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWU124

Oral insulin secretagogues, insulin, and cancer risk in type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWU124

Prevalence of diagnosed cancer according to duration of diagnosed diabetes and current insulin use among U.S. adults with diagnosed diabetes: findings from the 2009 Behavioral Risk Factor Surveillance System

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWU124

Mortality and other important diabetes-related outcomes with insulin vs other antihyperglycemic therapies in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWU124

Lung Cancer Chemoprevention: A Randomized, Double-Blind Trial in Linxian, China

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWU124